Analystreport

Jounce Therapeutics, Inc. (NASDAQ: JNCE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock, up previo

Jounce Therapeutics, Inc.  (JNCE) 
Last jounce therapeutics, inc. earnings: 2/27 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.jouncetx.com